Darya-Varia Laboratoria Tbk (DVLA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Darya-Varia Laboratoria Tbk (DVLA) has a cash flow conversion efficiency ratio of 0.063x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp94.03 Billion ≈ $5.51 Million USD) by net assets (Rp1.49 Trillion ≈ $87.49 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See DVLA equity financing ratio to measure how much of total assets are equity-financed.
Darya-Varia Laboratoria Tbk - Cash Flow Conversion Efficiency Trend (2000–2024)
This chart illustrates how Darya-Varia Laboratoria Tbk's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check earnings quality score of Darya-Varia Laboratoria Tbk to evaluate the quality of earnings relative to operating cash generation.
Darya-Varia Laboratoria Tbk Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Darya-Varia Laboratoria Tbk ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Renascor Resources Ltd
AU:RNU
|
0.003x |
|
Nova Klúbburinn hf.
IC:NOVA
|
N/A |
|
Dhampur Sugar Mills Limited
NSE:DHAMPURSUG
|
0.483x |
|
Maywood Acquisition Corp. 2 Class A Ordinary Share
NASDAQ:MYX
|
-1.341x |
|
Intema Insaat ve Tesisat Malzemeleri Yatirim ve Pazarlama AS
IS:INTEM
|
-0.034x |
|
Interojo Inc
KQ:119610
|
0.046x |
|
Black Diamond Therapeutics Inc
NASDAQ:BDTX
|
-0.098x |
|
Golf & Co Group Ltd
TA:GOLF
|
0.136x |
Annual Cash Flow Conversion Efficiency for Darya-Varia Laboratoria Tbk (2000–2024)
The table below shows the annual cash flow conversion efficiency of Darya-Varia Laboratoria Tbk from 2000 to 2024. For the full company profile with market capitalisation and key ratios, see Darya-Varia Laboratoria Tbk stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Rp1.45 Trillion ≈ $84.90 Million |
Rp331.76 Billion ≈ $19.44 Million |
0.229x | +194.51% |
| 2023-12-31 | Rp1.40 Trillion ≈ $82.29 Million |
Rp109.19 Billion ≈ $6.40 Million |
0.078x | +779.46% |
| 2022-12-31 | Rp1.40 Trillion ≈ $82.25 Million |
Rp-16.06 Billion ≈ $-941.06K |
-0.011x | -103.63% |
| 2021-12-31 | Rp1.38 Trillion ≈ $80.91 Million |
Rp435.33 Billion ≈ $25.51 Million |
0.315x | +292.32% |
| 2020-12-31 | Rp1.33 Trillion ≈ $77.72 Million |
Rp106.58 Billion ≈ $6.25 Million |
0.080x | -61.49% |
| 2019-12-31 | Rp1.31 Trillion ≈ $76.53 Million |
Rp272.54 Billion ≈ $15.97 Million |
0.209x | +840.57% |
| 2018-12-31 | Rp1.20 Trillion ≈ $70.33 Million |
Rp26.63 Billion ≈ $1.56 Million |
0.022x | -89.27% |
| 2017-12-31 | Rp1.12 Trillion ≈ $65.41 Million |
Rp230.74 Billion ≈ $13.52 Million |
0.207x | +19.03% |
| 2016-12-31 | Rp1.08 Trillion ≈ $63.26 Million |
Rp187.48 Billion ≈ $10.99 Million |
0.174x | -21.06% |
| 2015-12-31 | Rp973.52 Billion ≈ $57.04 Million |
Rp214.17 Billion ≈ $12.55 Million |
0.220x | +102.73% |
| 2014-12-31 | Rp962.43 Billion ≈ $56.39 Million |
Rp104.44 Billion ≈ $6.12 Million |
0.109x | -7.18% |
| 2013-12-31 | Rp914.70 Billion ≈ $53.60 Million |
Rp106.93 Billion ≈ $6.27 Million |
0.117x | -17.47% |
| 2012-12-31 | Rp841.55 Billion ≈ $49.31 Million |
Rp119.21 Billion ≈ $6.99 Million |
0.142x | +42.19% |
| 2011-12-31 | Rp727.92 Billion ≈ $42.65 Million |
Rp72.52 Billion ≈ $4.25 Million |
0.100x | -51.14% |
| 2010-12-31 | Rp640.60 Billion ≈ $37.54 Million |
Rp130.61 Billion ≈ $7.65 Million |
0.204x | +1888.91% |
| 2009-12-31 | Rp554.92 Billion ≈ $32.52 Million |
Rp5.69 Billion ≈ $333.34K |
0.010x | -96.31% |
| 2008-12-31 | Rp507.85 Billion ≈ $29.76 Million |
Rp141.00 Billion ≈ $8.26 Million |
0.278x | +37.27% |
| 2007-12-31 | Rp462.23 Billion ≈ $27.08 Million |
Rp93.49 Billion ≈ $5.48 Million |
0.202x | +41.12% |
| 2006-12-31 | Rp412.31 Billion ≈ $24.16 Million |
Rp59.09 Billion ≈ $3.46 Million |
0.143x | -24.56% |
| 2005-12-31 | Rp390.60 Billion ≈ $22.89 Million |
Rp74.21 Billion ≈ $4.35 Million |
0.190x | +8.87% |
| 2004-12-31 | Rp319.03 Billion ≈ $18.69 Million |
Rp55.67 Billion ≈ $3.26 Million |
0.174x | -29.75% |
| 2003-12-31 | Rp273.48 Billion ≈ $16.02 Million |
Rp67.93 Billion ≈ $3.98 Million |
0.248x | -8.28% |
| 2002-12-31 | Rp227.09 Billion ≈ $13.31 Million |
Rp61.50 Billion ≈ $3.60 Million |
0.271x | +12.46% |
| 2001-12-31 | Rp163.55 Billion ≈ $9.58 Million |
Rp39.39 Billion ≈ $2.31 Million |
0.241x | +28.10% |
| 2000-12-31 | Rp170.17 Billion ≈ $9.97 Million |
Rp31.99 Billion ≈ $1.87 Million |
0.188x | -- |
About Darya-Varia Laboratoria Tbk
PT Darya-Varia Laboratoria Tbk manufactures and trades pharmaceutical products and cosmetics in Indonesia. It operates in four segments: Prescription Drugs, Consumer Health Products, Export and Toll Manufacturing Services, and Services. The company offers prescription products in various areas of cardiology, analgesics, gastro-hepatology, dermamedic, somatic, cough and cold, antibiotic, women hea… Read more